Detalhe da pesquisa
1.
Eosinophilic fasciitis (Shulman syndrome)-recognition of the histological spectrum allows for new insights into possible pathomechanisms.
Rheumatology (Oxford)
; 62(5): 2005-2014, 2023 05 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36130069
2.
Rituximab plus leflunomide in rheumatoid arthritis: a randomized, placebo-controlled, investigator-initiated clinical trial (AMARA study).
Rheumatology (Oxford)
; 60(11): 5318-5328, 2021 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33738492
3.
Systemic sclerosis-associated myositis features minimal inflammation and characteristic capillary pathology.
Acta Neuropathol
; 141(6): 917-927, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33864496
4.
Pain and Fatigue in Patients With Ankylosing Spondylitis Treated With Tumor Necrosis Factor Inhibitors: Multinational Real-World Findings.
J Clin Rheumatol
; 27(8): e446-e455, 2021 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32826654
5.
Correction to: Osteoporosis in patients with rheumatoid arthritis: trends in the German National Database 2007-2017.
Rheumatol Int
; 40(12): 2013, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33064162
6.
Osteoporosis in patients with rheumatoid arthritis: trends in the German National Database 2007-2017.
Rheumatol Int
; 40(12): 2005-2012, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32377959
7.
Abatacept retention and clinical outcomes in Austrian patients with rheumatoid arthritis: real-world data from the 2-year ACTION study.
Wien Med Wochenschr
; 170(5-6): 132-140, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31654156
8.
Effects of BI 655064, an antagonistic anti-CD40 antibody, on clinical and biomarker variables in patients with active rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase IIa study.
Ann Rheum Dis
; 78(6): 754-760, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30902820
9.
Call for action: how to improve use of patient-reported outcomes to guide clinical decision making in rheumatoid arthritis.
Rheumatol Int
; 38(6): 935-947, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29564549
10.
Antimodified protein antibody response pattern influences the risk for disease relapse in patients with rheumatoid arthritis tapering disease modifying antirheumatic drugs.
Ann Rheum Dis
; 76(2): 399-407, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27323772
11.
Lesinurad monotherapy in gout patients intolerant to a xanthine oxidase inhibitor: a 6 month phase 3 clinical trial and extension study.
Rheumatology (Oxford)
; 56(12): 2170-2178, 2017 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29029210
12.
[This is how we treat rheumatoid nodules in patients with rheumatoid arthritis in remission]. / So behandeln wir Rheumaknoten bei Patienten mit rheumatoider Arthritis in Remission.
Z Rheumatol
; 81(7): 605-607, 2022 09.
Artigo
em Alemão
| MEDLINE | ID: mdl-35723718
13.
Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled RETRO study.
Ann Rheum Dis
; 75(1): 45-51, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25660991
14.
Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatment.
Ann Rheum Dis
; 75(9): 1637-44, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26483255
15.
Efficacy and prognostic factors of treatment retention with intravenous abatacept for rheumatoid arthritis: 24-month results from an international, prospective, real-world study.
Clin Exp Rheumatol
; 34(3): 489-99, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26966919
16.
Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept.
BMC Musculoskelet Disord
; 17: 231, 2016 05 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-27229685
17.
Hypothalamic-pituitary-adrenal axis function in patients with rheumatoid arthritis treated with different glucocorticoid approaches.
Neuroimmunomodulation
; 22(1-2): 83-8, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25228310
18.
Prognostic factors for abatacept retention in patients who received at least one prior biologic agent: an interim analysis from the observational, prospective ACTION study.
BMC Musculoskelet Disord
; 16: 176, 2015 Jul 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-26228643
19.
Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial.
Lancet
; 381(9877): 1541-50, 2013 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-23515142
20.
Long-term safety and efficacy of abatacept in patients with rheumatoid arthritis and an inadequate response to methotrexate: a 7-year extended study.
Clin Exp Rheumatol
; 32(4): 553-62, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25005467